Cited in:


This article has been cited by:

  1. 1
    Hung-Ming Wang, Nai-Ming Cheng, Li-Yu Lee, Yu-Hua Dean Fang, Joseph Tung-Chieh Chang, Din-Li Tsan, Shu-Hang Ng, Chun-Ta Liao, Lan-Yan Yang, Tzu-Chen Yen, Heterogeneity of 18F-FDG PET combined with expression of EGFR may improve the prognostic stratification of advanced oropharyngeal carcinoma, International Journal of Cancer, 2016, 138, 3
  2. 2
    Trille Kristina Kjær, Christoffer Johansen, Elo Andersen, Randi Karlsen, Anni Linnet Nielsen, Kirsten Frederiksen, Mikael Rørth, Else Ibfelt, Susanne Oksbjerg Dalton, Influence of social factors on patient-reported late symptoms: Report from a controlled trial among long-term head and neck cancer survivors in Denmark, Head & Neck, 2016, 38, 3
  3. 3
    Lisa Buckley, Ruta Gupta, Bruce Ashford, Joe Jabbour, Jonathan R. Clark, Oropharyngeal cancer and human papilloma virus: evolving diagnostic and management paradigms, ANZ Journal of Surgery, 2016, 86, 1-2
  4. 4
    Damien Urban, June Corry, Ben Solomon, Annette M. Lim, Tsien Fua, Andrew Coleman, Ieta D'Costa, Albert Tiong, Chen Liu, Lester J. Peters, Danny Rischin, Weekly cisplatin and radiotherapy for low risk, locoregionally advanced human papillomavirus–positive oropharyngeal squamous cell carcinoma, Head & Neck, 2016, 38, 3
  5. 5
    R J Young, D Urban, C Angel, J Corry, B Lyons, N Vallance, S Kleid, T A Iseli, B Solomon, D Rischin, Frequency and prognostic significance of p16INK4A protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma, British Journal of Cancer, 2015, 112, 6, 1098